R1 RCM Inc. (NASDAQ:RCM) Q4 2023 Earnings Conference Call February 27, 2024 8:00 AM ET

Company Participants

Evan Smith - Investor Relations

Lee Rivas - Chief Executive Officer

Jennifer Williams - Chief Financial Officer

Conference Call Participants

Craig Hettenbach - Morgan Stanley

Jailendra Singh - Truist Securities

Stephanie Davis - Barclays

Charles Rhyee - TD Cowen

Daniel Grosslight - Citi

Sean Dodge - RBC Capital Markets

Elizabeth Anderson - Evercore Partner

Vikram Kesavabhotla - Baird

Allen Lutz - Bank of America

Operator

Good day. My name is Ellie, and I will be your conference operator for today. At this time, I would like to welcome everyone to the R1 RCM Incorporated Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions] Thank you.

Evan Smith, you may now begin the conference.

Evan Smith

Thank you, operator, and good morning.

Certain statements made during this call may be considered forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In particular, any statements about our future growth plans and performance, including statements about our strategic and cost savings initiatives, our liquidity position, our growth opportunities and our future financial performance are forward-looking statements. These statements are often identified by the use of words such as anticipate, believe, estimate, intend, design, may, plan, project, would and similar expressions or variations. Investors are cautioned not to place undue reliance on such forward-looking statements.

All forward-looking statements made on today's call involve risks and uncertainties. While we may elect to update these forward-looking statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. Our results and our outcomes may differ materially from those included in these forward-looking statements and as a result of various factors, including, but not limited to, economic downturns and market conditions beyond our control, including high inflations, the quality of global financial markets, or the ability to timely and successfully achieve the anticipated benefits of potential synergies of the acquisitions of Cloudmed and Acclara, our ability to retain existing customers or acquire new customers, the development of markets for our revenue cycle management offering, variability in lead time of prospective customers, competition within the market and factors discussed under the heading Risk Factors in our most recent annual report on Form 10-K.